Search Results

You are looking at 1 - 5 of 5 items for

  • Author or Editor: William A. Moats x
  • Refine by Access: All Content x
Clear All Modify Search

Abstract

Objective—To develop a multiple-residue screening method for the detection of β-lactams in bovine urine.

Animals—6 clinically normal Holstein cows and 6 calves.

Procedure—Pooled urine obtained from cows was used as a negative-control sample or spiked with varying concentrations of 6 β-lactam antibiotics. Urine samples were prepared for liquid chromatography by diluting 1 ml of urine with 9 ml of 0.01M KH2PO4, 0.01M Na2PO4, and filtering. Filtrate (2,000 ml) was eluted with a mobile phase in a gradient program. A fraction corresponding to each β-lactam of interest was collected and evaporated to < 1 ml, and water then was added to achieve a 1ml volume. The collected fraction was tested, using a microbial inhibition test. Then, calves were fed milk spiked with a mixture of 5 β-lactam antibiotics at a concentration 40X the FDA tolerance in milk. Three hours following the feeding, urine samples were obtained from the calves and tested, as described for the urine samples for the cows.

Results—The lowest concentrations of amoxicillin, ampicillin, cephapirin, cloxacillin, desfuroylceftiofurcysteine, and penicillin G that were consistently detected in urine were 100, 10, 100, 250, 1,000, and 10 ng/ml, respectively. Amoxicillin, ampicillin, cephapirin, cloxacillin, desacetylcephapirin, and penicillin G were detected in urine samples of 6/6, 5/6, 0/6, 6/6, 2/6, and 3/6 calves respectively, fed antibiotic- spiked milk.

Conclusions and Clinical Relevance—The integrated method described can be used to detect or identify β-lactam antibiotics in bovine urine. This method can be used to test cattle for β-lactam residues. (Am J Vet Res 2001;62:326–330)

Full access
in American Journal of Veterinary Research

SUMMARY

A radioimmunoassay test for tetracyclines (Charm II) was compared with high-pressure liquid chromatography (hplc) for detection of oxytetracycline (otc) residues in milk samples from individual lactating cows. Oxytetracycline was administered by 1 of 3 routes (IV, IM, or intrauterine) to 21 lactating dairy cows. A total of 292 duplicate milk samples were collected from milkings before and through 156 hours after otc administration. Concentration of otc in these samples was determined by use of the Charm II test and an hplc method with a lower limit of quantitation, approximately 2 ng of otc/ml. Samples were also classified with respect to presence of otc residues relative to the fda safe concentration (< 30 ng/ml), using the Charm II (by control point determination) and hplc methods.

There was a significant (P < 0.05) difference between test methods in classification of milk samples with respect to presence or absence of otc at the fda safe concentration. A total of 48 of the 292 test results (16.4%) did not agree. Using the hplc test results as the standard with which Charm II test results were compared, 47 false presumptive-violative test results and 1 false presumptive-nonviolative Charm fi test result (a sample containing 31 ng of otc/ml, as evaluated by hplc) were obtained. The samples with false presumptive-violative Charm fi results contained < 30 ng of otc/ml, as evaluated by hplc.

In some respects, the Charm H test performed appropriately as a screening test to detect otc residues in milk samples from individual cows. However, the tendency for the test to yield presumptive-violative test results at otc concentrations lower than the fda safe concentration (as evaluated by hplc), suggests that caution should be exercised in using the test as the sole basis on which a decision is made to reject milk. As indicated by the manufacturer, presumptive-violative Charm II test results should be confirmed by additional testing. Although not specifically evaluated, the tendency for misclassification of milk samples as presumptive-violative by the Charm II test may or may not occur in commingled milk, compared with milk samples from individual cows.

Free access
in American Journal of Veterinary Research

Abstract

Objective

To compare results of 6 commercially available milk antimicrobial screening tests with results of liquid chromatography (LC) when testing milk samples from individual cows treated for mild clinical mastitis by intramammary (IMM) infusion with amoxicillin or penicillin G.

Animals

6 cows with noninduced clinical mastitis: 3 treated by IMM infusion with amoxicillin and 3 treated by IMM infusion with penicillin G.

Procedure

Composite milk samples were collected before, during, and after treatment. Samples were assayed by use of the screening tests and their results and those of LC were compared. The LC results were assumed to represent the true result.

Results

Results of screening tests compared well with results of LC, with agreement of 94%. Positive screening test results for samples containing drug values below the established tolerance or safe level, as evaluated by LC, were obtained from 2 cows in which abnormal milk, as well as marked increases in composite milk somatic cell count, were observed. With the exception of 1 test in 1 cow, all screening tests had negative results at the end of the labeled milk-withholding time.

Conclusions and Clinical Implications

On the basis of results of the limited sample reported, the screening tests appeared to provide good agreement overall, compared with LC results, when testing milk of individual cows treated by IMM infusion with amoxicillin or penicillin G. Positive screening test results for milk samples containing amoxicillin or penicillin G at values below the established tolerance or safe level, as evaluated by LC, may occasionally be obtained. (Am J Vet Res 1998;59:1096-1100)

Free access
in American Journal of Veterinary Research

Abstract

Objective

A microbial receptor assay method (MRAM; Charm II test) for β-lactam antibiotics and a liquid chromatography (LC) method with a detection limit of 2 to 5 ppb were evaluated for detection of ampicillin or amoxicillin residues in milk samples from individuell cows.

Design

The MRAM was compared to the LC in 2 respects. Measured concentrations of drugs were compared, as well as the classification of samples relative to the FDA tolerance value of 10 ppb.

Animals

A total of 6 clinically normal lactating Holstein cows were used per drug.

Procedure

Ampicillin trihydrate or amoxicillin trihydrate was administered at an extra-label dosage of 22 mg/kg of body weight, IM, once to each of 6 cows/drug. Milk samples were collected at milkings prior to and for 156 hours after drug administration. Drug concentrations in milk samples from individual cows were determined by use of the MRAM and LC tests. Additionally, the classification of milk samples relative to the presence or absence of residues above the FDA tolerance value was determined. Pharmacokinetic analysis was performed on derived milk drug concentrations.

Results

Concentration of ampicillin in milk samples from all cows was < 10 ppb by the MRAM and LC methods by the fourth milking (48 hours) after treatment with ampicillin. Values were < 10 ppb by both methods for all cows treated with amoxicillin by the sixth milking (72 hours) after treatment. For individual milk samples, significant differences were found between test methods in the proportion of positive (failing) tests; the MRAM had a higher proportion of presumptive positives.

Conclusions

Even at an extra-label dosage of 22 mg/kg, IM, milk residues > 10 ppb (the FDA tolerance value) were not detected beyond the label milk withholding times for ampicillin (48 hours) and amoxicillin (96 hours). When used for testing milk of individual cows by the control point procedure, the MRAM had a tendency to give presumptive positive test results for milk samples containing < 10 ppb ampicillin or amoxicillin as determined by LC. (Am J Vet Res 1996;57:73-78)

Free access
in American Journal of Veterinary Research

SUMMARY

Milk antimicrobial residues are a serious concern for the dairy industry. Residues of the tetracycline family of antimicrobials have been reported in market milk by investigators, using radioimmunoassay and microbial receptor technology (hereafter referred to as the Charm II test). In response to these reports, an investigation was conducted to determine the potential of 3 extra-label routes of oxytetracycline (otc) administration to cause milk residues above the Food and Drug Administration safe value of 30 parts per billion (ppb). Lactating Holstein cows were administered otc once by use of 1 of 3 routes: iv at 16.5 mg/kg of body weight (n = 6); im at 11 mg/kg (n = 6); and intrauterine (iu) at 2 g in 500 ml of saline solution/cow (n = 6). Duplicate milk samples were collected at the milking prior to drug administration and for the next 13 milkings at 12-hour intervals. Concentrations of otc in milk samples were analyzed by use of the Charm II test for tetracyclines (lmit of otc detection, approx 5 ppb) and were compared with concentrations determined by use of a high-performance lquid chromatography (hplc) method (lower lmit of otc quantitation, approx 2 ppb).

The potential for milk otc residues above the Food and Drug Administration safe value of 30 ppb after treatment was considerably greater for the iv and im routes, compared with the iu route. Mean peak otc concentrations in milk at the first milking after treatment for the hplc and Charm II tests were approximately 3,700 to 4,200 ppb for the iv route, 2,200 to 2,600 ppb for the im route, and 186 to 192 ppb for the iu route, respectively.

Pharmacokinetic analysis, based on milk otc concentrations, indicated that the area under the curve (auc) and milk maximal concentration (Cmax) differed significantly (P < 0.001) among routes of administration. The auc was similar for iv and im administrations; values for both were greater than the auc for iu administration. The Cmax was greatest for iv, intermediate for im, and least for iu administration. There were significant (P ≤ 0.01) differences in auc between assay methods (Charm II vs hplc) for the iv route. Concentrations of otc in milk determined by the Charm II test were often greater than those determined by hplc.

Administration of otc to lactating cows via these routes is extra-label drug use. Failure to withhold the product from early milkings of cows administered otc by the iv or im route should be considered a potential cause of otc residues in market milk. Milk from nearly all cows contained otc (< 30 ppb), the Food and Drug Administration safe level, by 120 hours after otc administration. Use of appropriate withholding times and antibiotic residue testing is indicated to avoid otc residues.

Free access
in American Journal of Veterinary Research